CRY - CryoLife, Inc.
| Previous Close | 24.64 |
| Open | 25.67 |
| Bid | 25.89 x 1000 |
| Ask | 25.92 x 1000 |
| Day's Range | 25.12 - 26.12 |
| 52 Week Range | 20.76 - 33.00 |
| Volume | 241,240 |
| Avg. Volume | 208,843 |
| Market Cap | 991M |
| Beta (3Y Monthly) | 0.66 |
| PE Ratio (TTM) | 590.00 |
| EPS (TTM) | 0.04 |
| Earnings Date | Feb 11, 2020 - Feb 17, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2015-12-09 |
| 1y Target Est | 35.20 |
- PR Newswire
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections. The E-nya thoracic stent graft will be manufactured at the Company's facility in Hechingen, Germany.
- GlobeNewswire
Cryptologic Releases 2019 Third Quarter Financial Results
TORONTO, Nov. 27, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended September 30, 2019. Selected.
- Simply Wall St.
Are Investors Undervaluing CryoLife, Inc. (NYSE:CRY) By 21%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of CryoLife, Inc...
- Thomson Reuters StreetEvents
Edited Transcript of CRY earnings conference call or presentation 30-Oct-19 9:30pm GMT
Q3 2019 CryoLife Inc Earnings Call
- Zacks
CryoLife (CRY) Q3 Earnings Top Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
CryoLife Reports Third Quarter 2019 Financial Results
ATLANTA , Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase ...
- Insider Monkey
Hedge Funds Have Never Been More Bullish On Cryolife Inc (CRY)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
- Zacks
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results
ATLANTA , Oct. 16, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will ...
- Simply Wall St.
Why CryoLife, Inc.’s (NYSE:CRY) Return On Capital Employed Might Be A Concern
Today we'll evaluate CryoLife, Inc. (NYSE:CRY) to determine whether it could have potential as an investment idea. In...
- PR Newswire
CryoLife to Participate in the Deutsche Bank 27th Annual Leveraged Finance Conference
ATLANTA , Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat ...
- Simply Wall St.
These 4 Measures Indicate That CryoLife (NYSE:CRY) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Zacks
CryoLife Enters Agreement With Endospan for Aortic Stent
CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.
- PR Newswire
CryoLife Enters Into Distribution Agreement with Endospan
NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into distribution and credit facility agreements with Endospan, as well as an option agreement to purchase Endospan. Endospan is an Israeli-based, privately-held developer of NEXUS™, the only endovascular stent graft system approved for the repair of both aneurysms and dissections in the aortic arch. The addition of NEXUS to CryoLife's highly differentiated branched aortic stent graft portfolio further strengthens the Company's position as a leader in the growing aortic repair market.
- PR Newswire
CryoLife to Participate in Upcoming Investor Conferences
ATLANTA , Aug. 29, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming investor ...
- GlobeNewswire
Cryptologic Releases 2019 Second Quarter Financial Results
TORONTO, Aug. 29, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended June 30, 2019. Selected.
- Simply Wall St.
Should You Be Worried About CryoLife, Inc.'s (NYSE:CRY) 1.2% Return On Equity?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Zacks
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
Overhyped toxic stocks are vulnerable to external shocks and burdened with huge amount of debt.
- Thomson Reuters StreetEvents
Edited Transcript of CRY earnings conference call or presentation 30-Jul-19 8:30pm GMT
Q2 2019 CryoLife Inc Earnings Call
- Newsfile
CSE New Listing - Cryptologic Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - August 2, 2019) - Cryptologic Corp. (CSE: CRY) is one of the latest new listings on the Canadian Securities Exchange, having previously traded as Vogogo under the symbol "VGO'.For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cryptologic" in the search box. Cannot view this video? Visit:http://www.investmentpitch.com/video/0_u0x68kvb/New-Listing-Cryptologic-Corp-CSECRYJohn Kennedy FitzGerald, President ...
Motley FoolCryoLife (CRY) Q2 2019 Earnings Call Transcript
CRY earnings call for the period ending June 30, 2019.
- Zacks
CryoLife (CRY) Surpasses Q2 Earnings and Revenue Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
CryoLife Reports Second Quarter 2019 Financial Results
ATLANTA , July 30, 2019 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% ...
- ACCESSWIRE
CryoLife, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July, 30 2019 / CryoLife, Inc. (NYSE: CRY ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July, 30 2019 at 4:30 PM Eastern Time. ...
- PR Newswire
CryoLife to Present at Canaccord Genuity 39th Annual Growth Conference
ATLANTA , July 25, 2019 CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Canaccord Genuity ...
